Canon Medical Systems Secures Top Honors at 2024 IMV ServiceTrak™ Awards
Tustin, Wednesday, 5 February 2025.
Canon Medical Systems USA has been recognized with Best Service and Best System Performance awards in General X-Ray, highlighting its commitment to innovative healthcare solutions and exceptional customer service.
Award Recognition Details
The prestigious accolades were announced during the Radiological Society of North America (RSNA) Annual Meeting in Chicago, where Canon Medical received two distinct honors in the General X-Ray category [1][2]. The IMV ServiceTrak™ Imaging Awards, presented by the Science and Medicine Group, are particularly significant as they are based on comprehensive feedback from imaging professionals across hospital departments and independent imaging centers throughout the United States [1].
Impact on Healthcare Delivery
This recognition comes at a time when the medical imaging industry is experiencing significant growth, with the global medical cameras market valued at 3.4 billion in 2024 and projected to reach 5.2 billion by 2030 [7]. Canon Medical’s achievement reflects its successful implementation of its ‘Made for Life’ philosophy, which prioritizes patient care and provider support in healthcare delivery [1][2].
Technology and Service Excellence
Tom Freund, Vice President of Service Operations at Canon Medical Systems USA, emphasized the company’s commitment to advancing healthcare through innovation and customer partnerships [1][2]. The company’s success aligns with broader industry trends, particularly in North America, which currently holds 40.2% of the global medical imaging market share [7].
Future Implications
Looking ahead, Canon Medical’s technological advancements are exemplified by their development of deep learning applications, as demonstrated in their Aquilion ONE Insight platform [6]. This innovative approach, combined with their award-winning service model, positions the company to contribute significantly to the projected 7.1% CAGR in the medical imaging market between 2024 and 2030 [7].